Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$18.4MFederal grants as PI21 awards
4Patents grantedLatest Oct 13, 2026
86Papers1,572 citations
Federal awards and patents by year
AwardsPatents
21 awards · $18.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 31, 2026 | NIH | SBIR Phase II Multispray Technology for Studying Biomolecular Interactions | $1.0M | NEWOMICS INC. |
| Aug 12, 2025 | NIH | SBIR Phase II Multispray Technology for Studying Biomolecular Interactions | $1.0M | NEWOMICS INC. |
| Aug 7, 2023 | NIH | SBIR Phase II Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics | $865K | NEWOMICS INC. |
| Sep 1, 2022 | NIH | SBIR Phase II Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics | $1.7M | NEWOMICS INC. |
| Aug 30, 2022 | NIH | SBIR Phase II Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics | $865K | NEWOMICS INC. |
| Mar 8, 2021 | NIH | SBIR Phase II Senescence-Chips for Radiation Biodosimetry | $997K | NEWOMICS INC. |
| Mar 27, 2020 | NIH | SBIR Phase II Senescence-Chips for Radiation Biodosimetry | $997K | NEWOMICS INC. |
| Jul 30, 2019 | NIH | SBIR Phase II AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease | $750K | NEWOMICS INC. |
| Apr 1, 2019 | NIH | SBIR Phase II Senescence-Chips for Radiation Biodosimetry | $3.0M | NEWOMICS INC. |
| Mar 27, 2019 | NIH | SBIR Phase II Senescence-Chips for Radiation Biodosimetry | $1.0M | NEWOMICS INC. |
| Sep 20, 2018 | NIH | SBIR Phase II AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease | $750K | NEWOMICS INC. |
| May 24, 2017 | NIH | SBIR Phase II Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells | $3K | NEWOMICS INC. |
| Apr 7, 2017 | NIH | SBIR Phase II Ultrahigh-throughput Identification of Molecular Targets of Natural Products | $811K | NEWOMICS INC. |
| Jan 26, 2017 | NIH | SBIR Phase II Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells | $750K | NEWOMICS INC. |
| Apr 18, 2016 | NIH | SBIR Phase II Ultrahigh-throughput Identification of Molecular Targets of Natural Products | $689K | NEWOMICS INC. |
| Feb 26, 2016 | NIH | SBIR Phase II Microfluidic Chips for Biomonitoring | $746K | NEWOMICS INC. |
| Jan 20, 2016 | NIH | SBIR Phase II Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells | $750K | NEWOMICS INC. |
| Aug 11, 2015 | NIH | SBIR Phase I Senescence-Chips for Radiation Biodosimetry | $300K | NEWOMICS INC. |
| Apr 30, 2015 | NIH | SBIR Phase I Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics | $342K | NEWOMICS INC. |
| Apr 8, 2015 | NIH | SBIR Phase I AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease | $350K | NEWOMICS INC. |
| Mar 13, 2015 | NIH | SBIR Phase II Microfluidic Chips for Biomonitoring | $750K | NEWOMICS INC. |
5 patents as inventor
- US 10338079NEWOMICS INC.Jul 2, 2019
- US 10627395NEWOMICS INC.Apr 21, 2020
- US 10928401NEWOMICS INC.Feb 23, 2021
- US 12761230NEWOMICS INC.Oct 13, 2026
- US NEWOMICS INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#11
Awards as PI#21
Patents#89
Companies
- NEWOMICS INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.